Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: time to get back to sharing information about Bioasis and blood-brain barrier technologies and companies
For me, it comes down to first clinical dose. Chiesi? I have no idea when. For XB3-001, I see Q1-2022 in the latest presentation. I hope I'm wrong but I'm skeptical. It will require funding through a partnership(?) and if I recall correctly, it takes a million bucks and a year to create xB3-based therapeutics. So, unfortunately, Q1-2022 for XB3-001 looks like a placeholder to me.
